Accelerating HPV vaccine access

Related program: Center for Vaccine Innovation and Access

From advancing new vaccine candidates to optimizing programmatic impact, PATH is working to accelerate the development, introduction, and uptake of vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Our impact
PATH's experience in cervical cancer spans decades
years of experience in cervical cancer prevention and treatment
national HPV vaccine introductions informed by PATH
HPV vaccine demonstration projects supported by PATH
Sign up for the HPVflash e-newsletter